News

September is Sepsis Awareness Month.

Marijke Vroomen Durning, Director of Content at Sepsis Alliance, authored the following blog post for BioMed Central about Sepsis and the importance of raising awareness.

http://blogs.biomedcentral.com/on-medicine/2017/09/04/sepsis-awareness-month-suspect-sepsis-save-lives/

Two new medicine fact sheets, clozapine and imipramine have been added to the resource.

A ginger CAM monograph has been added online to provide evidence-based pregnancy and breastfeeding safety information.

All 65 psychotropic medicine profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.

Two new medicine monographs, ingenol mebutate and secukinumab have been added online.

CKN now provides access to Oxford's A Dictionary of Occupational Science and Occupational Therapy.

This dictionary provides up-to-date definitions of the terms used in the related fields of occupational science and occupational therapy. Entries cover a broad range of topics from activities of daily living and autonomy to task-oriented approach and work–life balance and have a clear occupational focus. They provide an overview of the complex nature of human occupation and the impact of illness, injury, social exclusion, marginalization, or transition, for example, on occupation and well-being. Descriptions and analysis are backed up by key theories from related areas such as anthropology, sociology, and medicine.

• A new therapeutic group: Complementary and alternative medicines (CAM) used in pregnancy and breastfeeding has been added to the website. This aims to provide general advice on the use of CAM in pregnancy and breastfeeding.
• A St John’s wort CAM monograph has been added online to provide evidence-based pregnancy and breastfeeding safety information.
• All 51 gastrointestinal medicine profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.
• An apremilast medicine monograph, a medicine used for the treatment of active psoriatic arthritis has been added online.

The July 2017 release of eTG Complete is now available and includes updated Pharmaceutical Benefits Scheme (PBS) information. If a drug is available on the PBS, there is an icon beside the dosing information in the blue dose panels. Click on the icon to check for information on PBS restrictions, brand names, pack sizes, number of repeats, and links to product information (PI) and consumer medicines information (CMI).

MIMS are updating medicine ingredient names as part of a push to support the Therapeutic Goods Administration (TGA) project to harmonise with names used internationally. 

MIMS will begin referring to these ingredients by their International Non-proprietary Names (INNs), however, users may continue to search by the old Australian Approved Names (AANs) if preferred.

A cumulative list of the changes can be found here: http://mims.com.au/index.php/news/ingredient-name-changes 

CKN is currently still in negotiations with Springer Publishing regarding continued access to Medications & Mothers' Milk.  The subscription expiry message currently posted on the product’s website does not relate to CKN and should be ignored.

Questions regarding the product should be directed to the CKN Help Desk not Springer.

Please contact CKN Support on 1300 308 174 or support@ckn.org.au.

Three new medicine profiles clobetasol, povidone iodine and wood tars have been added.

A new therapeutic group: Medicines for the treatment of head lice has been added to the website. This aims to provide general advice on the use of targeted agents in pregnancy and breastfeeding.

All twenty-nine obstetric and gynaecological medcine profiles and twenty-nine respiratory medicine profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.

ISABEL has upgraded their platform to provide a better mobile access experience. The changes allow you access to a fully compatible system on your mobile devices, laptops, tablets, etc. In addition, the latest version provides access to more robust resources like Merck Manual Professional and Medscape on all devices. You can use new features like the Likelihood Indicator as well as take advantage of the Causative Drugs feature on all devices.

An app is no longer required for mobile access. Simply access ISABEL from the CKN website on your phone or tablet from the Point of Care page. You will not be required to enter any additional institutional login details.